Business Briefs
Chicago Sun Times, IL - 17 Dec 2002
... Forest Laboratories Inc., the maker of the Celexa and Lexapro antidepressants, will
split its stock 2-for-1 on Jan. 8 to shareholders of record as of Dec. 23. ...

Forest Laboratories to Split Stock
Newsday - 17 Dec 2002
The Manhattan-based maker of antidepressants Celexa and Lexapro has about
181 million shares outstanding. The new shares will be distributed Jan. ...

Corporate report
Sarasota Herald-Tribune, FL - 17 Dec 2002
... The New York-based maker of antidepressants Celexa and Lexapro has about 181
million shares outstanding. Shares were $98.42, up $1.47. ICT Group Inc. ...

Forest Labs Sets Stock Split
Newsday - 16 Dec 2002
The New York-based maker of antidepressants Celexa and Lexapro has about 181
million shares outstanding. The new shares will be distributed Jan. ...

Drug firms and doctors: the offers pour in
Boston Globe, MA - 15 Dec 2002
... including Forest Pharmaceuticals, which promised the doctors $500 each for listening
to a Saturday morning talk about the firm's new antidepressant, Lexapro ...

RESEARCH ALERT-UBS Warburg cuts Forest Labs
Forbes - 09 Dec 2002
... CJ Sylvester raised his 2003 earnings per share estimate to $3.65 from $3.52 based
on anticipated strong sales of Forest's antidepressants Celexa and Lexapro ...

Forest, Recordati Shares Dive on Delay
ABC News - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest, Recordati Shares Dive on Delay
Reuters, UK - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest, Recordati Shares Dive on Delay
ABC News - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest, Recordati Shares Dive on Delay
Reuters, UK - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest Updates Status of Lercanidipine Regulatory Submission
Newsday - 06 Dec 2002
... Forest’s growing line of products includes: Lexapro(TM), indicated as initial as
well as maintenance treatment of major depressive disorder; Celexa(TM), also ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 25 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 24 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 23 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 22 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...